secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001104659-26-017585
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical reports Q4 growth, 2026 outlook; Ortenzio take-private bid under review
--------------------------------------------------------------------------------

- Q4 revenue $1,396.6M (+6.4%), net income $37.7M, diluted EPS $0.16 vs loss $0.19 YoY.
- FY2025 revenue $5,452.8M (+5.1%), net income $214.5M (+65%), adjusted EPS $1.16 (+23.4%).
- Rehab hospital segment revenue +15.2%, Adj EBITDA +11.1%. Outpatient rehab margin fell to 3.4% from 8.3%.
- 2026 outlook: revenue $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32.
- Board declares $0.0625 dividend; $1B stock repurchase authorized through Dec 2027; Ortenzio take-private proposal under review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465926017585/0001104659-26-017585-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465926017585/tm266741d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-017585

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer